https://www.marketscreener.com/quote/stock/ASCENTAGE-PHARMA-GROUP-IN-103501689/news/Ascentage-Pharma-Announces-First-Patient-Dosed-in-the-Registrational-Phase-III-Study-of-Olverembatin-45086470/?utm_source=telegram&utm_medium=social&utm_campaign=share